3689 Stock Overview
An investment holding company, primarily operates private hospitals in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Guangdong Kanghua Healthcare Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.00 |
| 52 Week High | HK$2.85 |
| 52 Week Low | HK$0.24 |
| Beta | 0.62 |
| 1 Month Change | -6.98% |
| 3 Month Change | -10.71% |
| 1 Year Change | 3.63% |
| 3 Year Change | -30.56% |
| 5 Year Change | -56.52% |
| Change since IPO | -81.13% |
Recent News & Updates
Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly
Nov 25
There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings
Sep 30Recent updates
Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly
Nov 25There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings
Sep 30Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Nov 28Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
May 09Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Feb 02Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly
Nov 08Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
Sep 06Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
May 31Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
Jan 25Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Sep 21Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?
May 03Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?
Feb 04
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14Shareholder Returns
| 3689 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | -1.9% |
| 1Y | 3.6% | -17.1% | 18.4% |
Return vs Industry: 3689 exceeded the Hong Kong Healthcare industry which returned -17.1% over the past year.
Return vs Market: 3689 underperformed the Hong Kong Market which returned 18.4% over the past year.
Price Volatility
| 3689 volatility | |
|---|---|
| 3689 Average Weekly Movement | 9.0% |
| Healthcare Industry Average Movement | 8.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.8% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 3689 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3689's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4,231 | Wangzhi Chen | www.kanghuagp.com |
Guangdong Kanghua Healthcare Group Co., Ltd., an investment holding company, primarily operates private hospitals in the People’s Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services.
Guangdong Kanghua Healthcare Group Co., Ltd. Fundamentals Summary
| 3689 fundamental statistics | |
|---|---|
| Market cap | HK$668.79m |
| Earnings (TTM) | HK$54.25m |
| Revenue (TTM) | HK$2.17b |
12.3x
P/E Ratio0.3x
P/S RatioIs 3689 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3689 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.72b |
| Gross Profit | CN¥319.78m |
| Other Expenses | CN¥268.91m |
| Earnings | CN¥50.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 15.68% |
| Net Profit Margin | 2.49% |
| Debt/Equity Ratio | 17.3% |
How did 3689 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 02:58 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Kanghua Healthcare Group Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ruyi Tang | BOCI Research Ltd. |
| Jing Qiang | China International Capital Corporation Limited |
| Yue-Kwong Lui | China Renaissance Securities |